Health and Healthcare

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

307 Articles

Chris Lange | Apr 26, 2017 at 11:30 AM EDT

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

24/7 Wall St. has put together a preview of some of the world’s largest biotech and pharma companies reporting their…

Chris Lange | Apr 26, 2017 at 9:40 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The April 13 short interest data have been compared with the previous report, and moves in the selected biotech stocks…

Chris Lange | Apr 12, 2017 at 9:10 AM EDT

Short Sellers Back Off Major Biotechs

The March 31 short interest data have been compared with the previous report, and short interest decreased in most of…

Jon C. Ogg | Mar 30, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Conoco, Goodyear, Humana, Lululemon, Range Resources and Many More

The top analyst upgrades, downgrades and initiations include ConocoPhillips, Goodyear Tire, Humana, Lululemon Athletica and Range Resources.

Chris Lange | Mar 27, 2017 at 10:30 AM EDT

Short Interest Pulls Back in Major Biotechs

The health care sector in general has rallied since Trump took over the presidency, but now that his repeal of…

Chris Lange | Mar 10, 2017 at 10:30 AM EST

Major Biotechs See a Retreat in Short Interest

The February 28 short interest data have been compared with the previous report, and short interest decreased in most of…

Chris Lange | Feb 28, 2017 at 10:15 AM EST

Short Sellers Hike Their Bets in Major Biotechs

The February 15 short interest data have been compared with the previous report, and short interest increased in all the…

Chris Lange | Feb 16, 2017 at 9:30 AM EST

How Alexion’s Pipeline Is Driving Earnings

Alexion Pharmaceuticals released a mixed most recent earnings report before the markets opened on Thursday.

Chris Lange | Feb 15, 2017 at 1:50 PM EST

The Top 5 Earnings Coming Out on Thursday

24/7 Wall St. has put together a preview of the most anticipated quarterly earnings reports that are on deck for…

Chris Lange | Feb 12, 2017 at 10:25 AM EST

Top 7 Earnings to Look For This Week

24/7 Wall St. has put together a preview of Cisco, Pepsico and some of the other most anticipated quarterly earnings…

Chris Lange | Feb 10, 2017 at 9:55 AM EST

Major Biotechs Scare Off Loads of Short Sellers

As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears…

Chris Lange | Jan 26, 2017 at 10:35 AM EST

Short Sellers Back Off Major Biotechs

As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears…

Chris Lange | Jan 12, 2017 at 9:35 AM EST

Biotech Short Sellers Run for Cover

As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what…

Lee Jackson | Jan 11, 2017 at 9:35 AM EST

JPMorgan Makes Big Changes to US Analyst Focus List for January

These are five top new picks that the JPMorgan team likes this month. All make good sense for growth portfolios.

Chris Lange | Jan 5, 2017 at 11:40 AM EST

Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday

As the markets are continuing to heat up, a few biopharma stocks made massive gains on Thursday. There is a…

1 … 9 10 11 12 13 … 21

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Back Off Major Biotechs

Top Analyst Upgrades and Downgrades: Conoco, Goodyear, Humana, Lululemon, Range Resources and Many More

Short Interest Pulls Back in Major Biotechs

Major Biotechs See a Retreat in Short Interest

Short Sellers Hike Their Bets in Major Biotechs

How Alexion’s Pipeline Is Driving Earnings

The Top 5 Earnings Coming Out on Thursday

Top 7 Earnings to Look For This Week

Major Biotechs Scare Off Loads of Short Sellers

Short Sellers Back Off Major Biotechs

Biotech Short Sellers Run for Cover

JPMorgan Makes Big Changes to US Analyst Focus List for January

Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Alexion Pharmaceuticals, Inc. : ALXN

All ALXN Articles

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Back Off Major Biotechs

Top Analyst Upgrades and Downgrades: Conoco, Goodyear, Humana, Lululemon, Range Resources and Many More

Short Interest Pulls Back in Major Biotechs

Major Biotechs See a Retreat in Short Interest

Short Sellers Hike Their Bets in Major Biotechs

How Alexion’s Pipeline Is Driving Earnings

The Top 5 Earnings Coming Out on Thursday

Top 7 Earnings to Look For This Week

Major Biotechs Scare Off Loads of Short Sellers

Short Sellers Back Off Major Biotechs

Biotech Short Sellers Run for Cover

JPMorgan Makes Big Changes to US Analyst Focus List for January

Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do